Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 4Active not recruiting 4Not yet recruiting 3Unknown 1Terminated 1

Sponsor Class

OTHER 2NETWORK 1INDUSTRY 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gynecologic 4Thoracic 1Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1Breast 1

Conditions

Prostatic Neoplasms 4Endometrial Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Breast Neoplasms 4Lung Neoplasms 3Leukemia, Myeloid, Acute 3Urinary Bladder Neoplasms 2Rectal Neoplasms 2Ovarian Neoplasms 2Neoplasm Metastasis 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Colonic Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Smoldering Multiple Myeloma 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Retinoblastoma 1Peritoneal Neoplasms 1Pathologic Complete Response 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neuroblastoma 1Neoplasms 1Mouth Neoplasms 1

Interventions

Paclitaxel 15pembrolizumab 13Carboplatin 12Specimen Handling 6Biopsy 6durvalumab 5Magnetic Resonance Spectroscopy 5dostarlimab 4Taxes 4Surveys and Questionnaires 4Observation 4Letrozole 4Everolimus 4olaparib 3lenvatinib 3ceralasertib 3Doxorubicin 3Cisplatin 3sacituzumab govitecan 2pertuzumab 2copanlisib 2cabozantinib 2atezolizumab 2abemaciclib 2Trastuzumab 2Nivolumab 2Metformin 2Megestrol Acetate 2Docetaxel 2Brachytherapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × Endometrial Neoplasms × Observation × Clear all
NCT01244789 2026-04-13

Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer

Danish Gynecological Cancer Group

Phase 2 Active not recruiting
244 enrolled
Gynecologic

Endometrial Neoplasms

NCT05179824 2025-05-06

Tempus Priority Study: A Pan-tumor Observational Study

Tempus AI

Active not recruiting
1,000 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmSarcomaThoracic

Bile Duct Neoplasms, Urinary Bladder Neoplasms, Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Lymphoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Skin Neoplasms, Stomach Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT06014580 2025-03-07

MADONNA

Latin American Cooperative Oncology Group

Active not recruiting
276 enrolled
Gynecologic

Endometrial Neoplasms

NCT03469674 2023-10-11

PORTEC-4a

Leiden University Medical Center

Phase 3 Active not recruiting
550 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡